✅ Product Benefits (English)

1. Rapid & Sustained Acid Suppression
   Dexlansoprazole, the R-enantiomer of lansoprazole, uses dual delayed‑release (DDR) granules to provide two plasma peaks (1–2 h and 4–5 h post-dose), offering extended gastric acid inhibition for symptom control and healing. Heals Erosive Esophagitis

2. A 60 mg once‑daily dose promotes healing of all grades of erosive esophagitis within 4–8 weeks. 

3. Maintains Healing & Controls Reflux
   After healing, 30 mg daily helps maintain remission and prevent heartburn recurrence for up to 6 months. Also used for symptomatic non-erosive GERD for a 4‑week course. 

4. Flexible Administration
   Can be taken with or without food. If necessary, capsule may be opened and granules sprinkled on food or water—do not chew. 

5. Convenient Once-Daily Dosing
   Simplifies treatment regimens with a once-daily oral dose.

6. Well-Tolerated with Favorable Safety Profile
   Mild side effects may include diarrhea, abdominal pain, nausea, vomiting, flatulence, and upper respiratory symptoms. Severe events like fractures, hypomagnesemia, or bone-related risks are rare. 

7. Minimal Dose Adjustment Needed
   Safe for elderly and patients with renal or mild hepatic impairment. Moderate hepatic impairment should restrict dosage to a maximum of 30 mg. Avoid use in severe hepatic disease. 

📋 Quick Facts

📝 Summary Overview

• Meta Title & Description focus on Delanzo’s innovative dual delayed‑release formulation and its primary roles: healing esophageal injury and controlling GERD.

• Meta Keywords include a wide mix of brand, generic, dosage, condition-based searches, and local context to maximize SEO reach.

• Benefits Section outlines the mechanism, therapeutic uses, ease of use, safety profile, and patient convenience all rooted in credible regulatory and clinical data.